Literature DB >> 7461723

The derivation of an inbred line of rats which develop asthma-like symptoms following challenge with aerosolized antigen.

G Holme, H Piechuta.   

Abstract

Sensitized Sprague-Dawley rats developed respiratory impairment after challenge with aerosolized antigen. The response to challenge was heterogeneous. A proportion of each group of rats developed dyspnea and other symptoms similar to asthma; the remainder developed apnea but no other symptoms. Selective breeding from rats which developed dyspnea increased the incidence from 44% in F0 to 55% in F1 and greater than 90% in F2 and F3. Inbreeding also produced a significant increase in the duration of antigen-induced dyspnea. The results from the selective inbreeding suggest antigen-induced dyspnea is controlled genetically, possibly by multiple gene loci. These inbred rats constitute a population which have a predictable response to aerosolized antigen challenge. They should have utility in investigating allergic asthma and evaluating potential new drugs.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7461723      PMCID: PMC1458206     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  Active bronchial anaphylaxis in the rat.

Authors:  L M Stotland; N N Share
Journal:  Can J Physiol Pharmacol       Date:  1974-12       Impact factor: 2.273

Review 2.  Animal models of the asthmatic state.

Authors:  R Patterson; J F Kelly
Journal:  Annu Rev Med       Date:  1974       Impact factor: 13.739

3.  Effect of disodium cromoglycate on various types of anaphylactic reaction in the guinea pig.

Authors:  W A Taylor; I M Roitt
Journal:  Int Arch Allergy Appl Immunol       Date:  1973

4.  Two lines of guinea pigs sensitive and nonsensitive to chemical mediators and anaphylaxis.

Authors:  Y Takino; K Sugahara; I Horino
Journal:  J Allergy       Date:  1971-05

5.  Effect of prostaglandins F2 alpha and E2 on airway conductance in healthy subjects and asthmatic patients.

Authors:  A A Mathé; P Hedqvist
Journal:  Am Rev Respir Dis       Date:  1975-03

6.  Immunochemical and biologic properties of rat IgE. I. Immunochemical identification of rat IgE.

Authors:  D J Stechschulte; R P Orange; K F Austen
Journal:  J Immunol       Date:  1970-11       Impact factor: 5.422

7.  Mediators of passive lung anaphylaxis in the rat.

Authors:  J B Farmer; I M Richards; P Sheard; A M Woods
Journal:  Br J Pharmacol       Date:  1975-09       Impact factor: 8.739

8.  IgE-mediated anaphylactic bronchoconstriction in the guinea pig and the effect of disodium cromoglycate.

Authors:  I F Carney
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

9.  Reagin-mediated asthma in rhesus monkeys and relation to bronchial cell histamine release and airway reactivity to carbocholine.

Authors:  R Patterson; K E Harris; I M Suszko; M Roberts
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

10.  The inhibition by dexamethasone and disodium cromoglycate of anaphylactic bronchoconstriction in the rat.

Authors:  M K Church; H O Collier; G W James
Journal:  Br J Pharmacol       Date:  1972-09       Impact factor: 8.739

View more
  4 in total

1.  Inhibition of allergen-induced bronchoconstriction in hyperreactive rats as a model for testing 5-lipoxygenase inhibitors and leukotriene D4 receptor antagonists.

Authors:  H Piechuta; A W Ford-Hutchinson; L G Letts
Journal:  Agents Actions       Date:  1987-10

Review 2.  Animal models for testing anti-inflammatory drugs for treatment of bronchial hyperreactivity in asthma.

Authors:  M J Linssen; O H Wilhelms; H Timmerman
Journal:  Pharm Weekbl Sci       Date:  1991-12-13

3.  Different strains of rats develop different clinical forms of adjuvant disease.

Authors:  V Y Muir; D C Dumonde
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

4.  The tripeptide FEG ameliorates systemic inflammatory responses to rat intestinal anaphylaxis.

Authors:  Fusun Turesin; Aida Sadr; Joseph S Davison; Ronald Mathison
Journal:  BMC Physiol       Date:  2002-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.